A real-life study on the impact of direct-acting antivirals in the treatment of chronic hepatitis C in liver transplant recipients at two university centers in Northeastern Brazil

The efficacy of direct-acting antivirals (DAAs) in the treatment of chronic hepatitis C (CHC) in liver transplant recipients is poorly understood, and several factors, including immunosuppression, drug interactions, elevated viraemia, and intolerance to ribavirin (RBV), can reduce cure rates. We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Isabella Patrícia Lima, Batista, Andrea Dória, Lopes, Edmundo Pessoa, Filgueira, Norma Arteiro, de Carvalho, Bernardo Times, Santos, Joelma Carvalho, de Medeiros, Tibério Batista, de Melo, Clarissa Ramos Lacerda, de Lima, Martha Sá, Lima, Kledoaldo, Lacerda, Claudio, Lacerda, Heloisa Ramos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845936/
https://www.ncbi.nlm.nih.gov/pubmed/33533809
http://dx.doi.org/10.1590/S1678-9946202163006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845936/
https://www.ncbi.nlm.nih.gov/pubmed/33533809
http://dx.doi.org/10.1590/S1678-9946202163006

Ejemplares similares